UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 187 filers reported holding UNIQURE NV in Q4 2019. The put-call ratio across all filers is 0.31 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $106,000 | -48.8% | 5,668 | +23.4% | 0.02% | -54.0% |
| Q2 2020 | $207,000 | -5.0% | 4,594 | 0.0% | 0.05% | -32.4% |
| Q1 2020 | $218,000 | -33.7% | 4,594 | 0.0% | 0.07% | +2.8% |
| Q4 2019 | $329,000 | -8.4% | 4,594 | 0.0% | 0.07% | -6.5% |
| Q2 2019 | $359,000 | +31.0% | 4,594 | 0.0% | 0.08% | +28.3% |
| Q1 2019 | $274,000 | +35.6% | 4,594 | -17.2% | 0.06% | +30.4% |
| Q3 2018 | $202,000 | -3.3% | 5,549 | +0.2% | 0.05% | -23.3% |
| Q2 2018 | $209,000 | – | 5,538 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 955,424 | $32,188,000 | 5.82% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 282,034 | $9,490,000 | 2.51% |
| Nantahala Capital Management | 1,672,891 | $56,360,000 | 1.65% |
| Henry James International Management Inc. | 149,053 | $5,022,000 | 1.51% |
| Nantahala Capital Management | 1,500,000 | $50,535,000 | 1.48% |
| Voss Capital, LLC | 90,000 | $3,032,000 | 1.26% |
| P.A.W. CAPITAL CORP | 30,000 | $1,011,000 | 0.89% |
| Sofinnova Investments, Inc. | 427,122 | $14,390,000 | 0.86% |
| Caption Management, LLC | 1,078,800 | $36,343,000 | 0.78% |
| Sivik Global Healthcare LLC | 61,768 | $2,081,000 | 0.76% |